Gene · 6395
Papers1,316
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,316
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Development of Gap-Recombinase Polymerase Amplification Combined with CRISPR-Cas12a (Gap-RPA/CRISPR-Cas12a) for Rapid Screening of α0-Thalassemia Southeast Asian (--SEA) Deletion and Thai (--THAI) Deletion. | Biology (Basel) | 2026 | 42792525 | PubTator, text mining | PubMed |
| Nanoplate Digital PCR for Identification of α0-Thalassemia (SEA Deletion): Carrier Screening and Possible Application to Prenatal Diagnosis. | Int J Mol Sci | 2026 | 42737742 | PubTator, text mining | PubMed |
| Resolving diagnostic complexity: long-read sequencing unmasks a Hong Kongαα/‒α4.2 genotype mimicking a heterozygous ‒α3.7 deletion on multiplex ligation-dependent probe amplification. | Lab Med | 2026 | 42574528 | PubTator, text mining | PubMed |
| A comparative study of SNPscan/CNVplex assay and routine PCR in genetic analysis of thalassemia. | Front Genet | 2026 | 42428940 | PubTator, text mining | PubMed |
| Characterization of a novel α-thalassemia deletion (Dongxing deletion; --DX) by CNV-seq in a Chinese female with Hb H disease: a case report. | Hematology | 2026 | 42321631 | PubTator, text mining | PubMed |
| Hemoglobin alpha-like subunit mu is expressed during ontogeny and is elevated in alpha thalassemia. | Blood Red Cells Iron | 2026 | 42004318 | PubTator, text mining | PubMed |
Study on the Potential Molecular Mechanisms of Sodium Dehydroacetate (Na-DHA) Interfering With Bone Metabolism and Inducing Osteoporosis Based on Network Toxicology, Molecular Docking, and In Vitro Experimental Validation. | Food Sci Nutr | 2026 | 41804343 | PubTator, text mining | PubMed |
| An Intramolecular Cobalt-Peptoid Complex as an Effective Catalyst for Light-Driven Water Oxidation at pH 7. | ACS Omega | 2026 | 41799071 | PubTator, text mining | PubMed |
| Epilepsy and Alzheimer Disease: Epidemiologic, Clinical, Molecular, and Neuropathologic Convergences and Divergences. | Neurol Clin Pract | 2026 | 41766754 | PubTator, text mining | PubMed |
| Determination of mean corpuscular haemoglobin cut-off point for differentiating alpha plus and alpha zero thalassaemia in thalassaemia screening. | Ann Hematol | 2026 | 41760930 | PubTator, text mining | PubMed |
| Activated partial thromboplastin time prolongation without hemorrhagic dienhesis: a study of a chinese family coexisting with hereditary KNG1 p.Arg240 mutation and --SEA/αα genotype thalassemia. | Ann Hematol | 2026 | 41634406 | PubTator, text mining | PubMed |
| Inorganic High-Performance Fiber-Based Materials for Electromagnetic Interference Shielding: Fundamentals, Fabrications, and Emerging Applications. | Nanomicro Lett | 2026 | 41611870 | PubTator, text mining | PubMed |
| Flexible MXene nanosheet/multiwall carbon nanotube-reinforced poly (vinylidene fluoride-hexafluoropropylene)-polymethyl methacrylate composites for energy storage and EMI shielding. | RSC Adv | 2026 | 41550813 | PubTator, text mining | PubMed |
| Relationship between staphylococcal enterotoxin superantigens and the development of chronic rhinosinusitis. | Medicine (Baltimore) | 2026 | 41517780 | PubTator, text mining | PubMed |
| Genomic and epidemiological insights into the emergence and dominance of MRSA clones in Riyadh's healthcare facilities. | Sci Rep | 2026 | 41495127 | PubTator, text mining | PubMed |
| IMPG2-associated retinal dystrophy with a novel missense variant and therapeutic options via adenine base editing. | Ophthalmic Genet | 2026 | 41478731 | PubTator, text mining | PubMed |
| Screening, genetic analysis, and clinical transfusion implications of thalassaemia and glucose-6-phosphate dehydrogenase deficiency in blood donors. | Transfus Med | 2026 | 41229149 | PubTator, text mining | PubMed |
| Current Therapies and Potential Strategies for Uveal Melanoma. | Drugs Drug Candidates | 2025 | 41737289 | PubTator, text mining | PubMed |
| [Screening Results of Thalassemia and Analysis of Rare Genotypes]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 41502270 | PubTator, text mining | PubMed |
| Tailoring Energy Absorption of Curved-Beam Lattices Through a Data-Driven Approach. | Materials (Basel) | 2025 | 41374219 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6395/papers